US경제·CNBC Business RSS· 번역 중
AI가 열심히 번역 중이에요 🤖
곧 한글 번역본을 제공해드릴게요. 잠시만 기다려주세요!
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
2026.07.21 23:54
AI 감성 분석
중립롱 50%숏 50%
이번 소송은 엘리리(Lilly)에게 규제 및 평판 위험을 야기하며, 매우 경쟁적인 GLP-1 시장에 즉각적인 불확실성을 추가합니다.
핵심 요약
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
Original Article
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.
Source: https://www.cnbc.com/2026/07/21/novo-nordisk-sues-eli-lilly-glp-1-ads.html